Article Details

German Merck's MS drug falls short in pair of Phase 3 tests | BioPharma Dive

Retrieved on: 2023-12-06 16:42:03

Tags for this article:

Click the tags to see associated articles and topics

German Merck's MS drug falls short in pair of Phase 3 tests | BioPharma Dive. View article details on hiswai:

Excerpt

The announcement is more bad news for a class of drugs known as BTK inhibitors. Just last week, Roche's Genentech unit said the Food and Drug ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up